Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pettit

Showing results (471-480 of 659) with videos related to

Pageof 66
Sort By:
Pancreas|July 6, 2000
Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancerZ He, J L Evelhoch, R M Mohammad, et al.
Journal of Natural Products|August 30, 2005
Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbeneGeorge R Pettit, Collin R Anderson, Eric J Gapud, et al.
Anticancer Research|May 23, 2002
Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumoursS E Holwell, P A Cooper, K Grosios, et al.
Journal of Medicinal Chemistry|May 31, 2002
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphateGeorge R Pettit, Matthew P Grealish, M Katherine Jung, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Synthesis and biological evaluation of a spongistatin AB-spiroketal analogueAmos B Smith, R Michael Corbett, George R Pettit, et al.
Cancer Research|February 15, 1996
Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase CX Zhang, R Zhang, H Zhao, et al.
Journal of Medicinal Chemistry|April 23, 1999
Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4G R Pettit, B E Toki, D L Herald, et al.
Journal of Natural Products|December 28, 2002
Isolation of labradorins 1 and 2 from Pseudomonas syringae pv. coronafaciensGeorge R Pettit, John C Knight, Delbert L Herald, et al.
Molecular Pharmacology|November 1, 1994
Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiationZ Szallasi, M F Denning, C B Smith, et al.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
Pageof 66

Showing results (471-480 of 659) with videos related to

Sort By:
Pageof 66
Pancreas|July 6, 2000
Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancerZ He, J L Evelhoch, R M Mohammad, et al.
Journal of Natural Products|August 30, 2005
Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbeneGeorge R Pettit, Collin R Anderson, Eric J Gapud, et al.
Anticancer Research|May 23, 2002
Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumoursS E Holwell, P A Cooper, K Grosios, et al.
Journal of Medicinal Chemistry|May 31, 2002
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphateGeorge R Pettit, Matthew P Grealish, M Katherine Jung, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Synthesis and biological evaluation of a spongistatin AB-spiroketal analogueAmos B Smith, R Michael Corbett, George R Pettit, et al.
Cancer Research|February 15, 1996
Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase CX Zhang, R Zhang, H Zhao, et al.
Journal of Medicinal Chemistry|April 23, 1999
Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4G R Pettit, B E Toki, D L Herald, et al.
Journal of Natural Products|December 28, 2002
Isolation of labradorins 1 and 2 from Pseudomonas syringae pv. coronafaciensGeorge R Pettit, John C Knight, Delbert L Herald, et al.
Molecular Pharmacology|November 1, 1994
Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiationZ Szallasi, M F Denning, C B Smith, et al.
British Journal of Cancer|October 1, 1994
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1J Prendiville, A T McGown, A Gescher, et al.
Pageof 66